Radiofrequency Ablation Therapy versus Stereotactic Body Radiation Therapy for Naive Hepatocellular Carcinoma (≤5cm): A Retrospective Multi-Center Study
The LC rates were better in the SBRT group than in the RFA group for the patients with lesions localized in S7/S8, and SBRT could also be a therapeutic option for patients with lesions in S1. Moreover, patients with tumors located in S5/S6 were better candidates for RFA treatment than SBRT.
Authors
- Lewei Duan (ORCID: https://orcid.org/0000-0003-0324-5655)
- Ting‐Shi Su (ORCID: https://orcid.org/0000-0003-3097-4394)
- Yanping Yang (ORCID: https://orcid.org/0000-0002-5102-3996)
- Xiaoyun Chang
- Wengang Li (ORCID: https://orcid.org/0000-0002-6980-1776)
- Tao Zhang (ORCID: https://orcid.org/0000-0003-1048-4443)
- Aimin Zhang (ORCID: https://orcid.org/0000-0002-5311-7021)
- Jing Sun (ORCID: https://orcid.org/0000-0002-4161-6835)
- Xiaofang Zhao
- Xuezhang Duan
- Wei-Ping He
Institutions
- Guangxi Medical University (CN)
- Anhui Medical University (CN)
- Fudan University (CN)
- Chinese PLA General Hospital (CN)
- Kaifeng City Children's Hospital (CN)
- PLA Academy of Military Science (CN)
Publication Details
- Journal
- Journal of Hepatocellular Carcinoma
- Published
- 2024-11-01
- DOI
- https://doi.org/10.2147/jhc.s488138
- Citations
- 5
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.85
Funders
- National Natural Science Foundation of China